Header for the 2012 NCRI Cancer Conference
NCRI Cancer Conference Newsletter
May 2012

Dear  

 

Don't miss this opportunity to present your research to the UK cancer research community and beyond - submit your abstract now for your work to be considered for oral and poster presentation. The closing date for abstract submission is Tuesday 5 June. Remember that your colleagues may also be interested in submitting - so feel free to .

 

Online registration opens Friday 1 June. Register before Tuesday 31 July to take advantage of our earlybird rates.

 

The 2012 NCRI Cancer Conference will present a top-quality scientific programme. We are pleased to bring you a preview of the parallel sessions in this edition of the newsletter.

 

Final call for abstracts: Abstract submission closes Tuesday 5 June

 

Submit an abstract onlineAbstracts must be submitted by Tuesday 5 June to be considered for oral and poster presentation, and to be entered into any of the six abstract prize competitions.

 

If you are finalising data which will be ready after this date, late breaking abstract submission will be open 1-28 August. However, the possibility of being selected for oral presentation is much reduced at this stage and no prizes are available.

 

These are the abstract prizes that are available for abstracts submitted by 5 June:

  • NCRI Prize Awards
  • British Association of Cancer Research (BACR)/Gordon Hamilton-Fairley Young Investigator Award
  • Children's Cancer and Leukaemia Group (CCLG) McElwain Award
  • Richard Hambro Student Prizes
  • AstraZeneca Student Prize Award
  • Royal College of Radiologists Ross Prizes

Please see the abstract prizes webpage for more information, including eligibility criteria.

 

Detailed abstract submission guidelines are available on the Conference website.

2012 programme preview

 

Parallel sessions now available! 

 

The programme for 2012 contains 22 parallel sessions within the six Conference themes.

 

A detailed programme is available on the Conference website - please check this for further details about all confirmed speakers and session times.

 

These are the topics that will be included in the parallel sessions:

 

Tumour-specific research

  • Liver malignancy
  • Haematological cancers
  • Ovarian cancer
  • Prostate cancer: The androgen receptor takes centre stage
  • Paediatric oncology  

 

The cancer cell and model systems

  • Mechanisms of drug resistance
  • Cold blooded cancer: Non-mammalian models for cancer research
  • Tumour angiogenesis
  • Cancer stem cells and tumour-initiating cells
  • Cell death, necroptosis and beyond 

 

Epidemiology and prevention

  • Aspirin and other anti-inflammatory drugs in cancer prevention
  • Cancer inequalities in the UK
  • Primary and secondary cancer prevention - lifestyle interventions
  • Human factors in early presentation 

 

Diagnosis and therapy

  • Predictive biomarker-driven phase II/III trials
  • Rational approaches to combination of cancer therapies
  • Drugging the undruggable - how to target proteins that are not enzymes
  • Surgery in the era of biomarkers and novel systemic and regional therapies

 

Information, patients and the public

  • Economics of cancer
  • Patients, participants and public - different perspectives but shared views? 

 

Survivorship and end-of-life care

  • Cachexia - relationship with cancer treatment toxicity and update on drug and non-drug approaches
  • Can this patient die comfortably at home?: Knowing the risks and what helps

Collaboration with the Royal College of Radiologists 

 

This year the programme for Tuesday 6 November has been developed in collaboration with the Royal College of Radiologists. There will be sessions throughout the day intended to appeal to clinical and medical oncologists in particular, including dedicated oral and poster sessions (for which a number of RCR Ross Prizes are available) and an RCR training session.

Travel awards

 

Sponsored by the European Association for Cancer Research

 

EACR Logo

This year there will be a number of travel awards available for non UK-based EU delegates. Please check the

travel awards webpage for full details.

Conference links

 

Sponsors and exhibitors

 

Information about sponsorship

 

Information about the Trade Exhibition

  

Archive
 


Registration opens 1 June 2012

Registration_2009_2

Register early for discounted rates, including our new double-day rates & reduced clinical consultant fees!

    

We are pleased to announce that registration for the 2012 NCRI Cancer Conference opens on Friday 1 June.

 

Delegates who register before Tuesday 31 July will benefit from our earlybird reduced registration fees.

 

We have increased the options for registration this year in response to delegate feedback received. You are now able to register for the entire Conference, for one day only or for two days only. We have also reduced the early bird registration fee for clinical consultants to £325 for the whole event.  

 

Please visit the Conference website for further information on registration options and prices.

Involving patients and carers

 

As usual at the Conference, our bursary holders will have a high profile, especially in the sessions that they are leading.

 

This year there is a session on 'Patients, participants and public - different perspectives but shared views?'. Hosted by Richard Stephens, the session will include an analysis of the answers in the 2011-12 National Cancer Experience Survey, in which 60,000 cancer patients were questioned about their support for, or involvment in, research.  

 

Welsh charity Tenovus will also be presenting findings on their innovation in inviting the public to suggest research priorities and patients to prioritise them. In the session Tenovus will be announcing the winner of the first grant made under this scheme.

 

For the first time, the NCRI's Consumer Liaison Group (CLG) will be holding their autumn meeting at the Conference. As part of the meeting, the group will be offering a "Dragons' Den" for researchers. Teams of consumers with experience in trial design or participation, or in portfolio management via Clinical Studies Groups, will be available for researchers to test ideas and move forward with their proposals.

 

Consumers 

"We have always wanted to use our collective expertise to help encourage, support and deliver patient and public involvement for trial proposals," explains Richard Stephens, incoming Chair of the CLG. "Having a meeting at the conference allows us to take the CLG into the research community more directly than we have done before. Potentially this gives a more effective impact at earlier stages of research design, as well as helping to build stronger long-term links between researchers and the CLG."   

 

Consumers - who may be patients, carers or members of the public with an interest in research - are also likely to provide some challenging audience contributions to the symposium on 'Palliative and supportive care' (hosted by Irene Higginson) as well as the plenary lectures from Harpal Kumar and Sir Michael Marmot on the independent review of the NHS Breast Screening Programme. 

 

"We consumers always enjoy the conference enormously," Richard says, "But we like to make a positive impact too, so that we give value for money for our bursaries, and above all so that we help keep the focus on research to improve outcomes for patient benefit." 

 

Please check the Bursaries for patients and carers webpage for full details and to apply.

Advertise in the Programme Book

 

Promote your organisation in the cancer research community

  

Advertising in the 2012 Programme Book offers an excellent opportunity to enhance your organisation's profile within the UK cancer community and beyond.

 

To find out more, or to discuss other sponsorship opportunities, please visit the sponsorship pages of the Conference website.

Important dates
Registration opens

Friday 1 June

  

Abstract submission closes

Tuesday 5

 

Bursaries for patients and carers - applications close

Friday 29 June

Late breaking abstract submission opens

Wednesday 1 August

 

Please visit the Conference website for other important dates.

Thank you for your interest in the NCRI Cancer Conference.

Remember that your colleagues may also be interested in submitting an abstract or in finding out more about the Conference -  to them now!

 

We look forward to receiving your abstract submissions soon.
 

With best wishes, 

NCRI Cancer Conference Secretariat
go to the NCRI Cancer Conference website

Illumina Cancer Seminar

Unraveling Cancer One Base at a Time, Leeds, 29th May

 

Join us to see the latest progress in the study of cancer. Learn how Illumina sequencing and microarray technologies are helping to drive new discoveries for the disease. Illumina solutions allow you to rapidly analyze a patient's unique cancer genome, epigenome, and transcriptome to elucidate the mechanisms underlying the disease, evaluate potential treatments, and even predict the risk of relapse.

 

To register for this event please use the following link: http://eventregistration.illumina.com/d/tcq1gf

 

Additional Illumina cancer seminars are scheduled in Europe, please contact pvalk@illumina.com for further details.

Illumina - Newsletter Sponsor

The National Cancer Research Institute
The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry. It promotes co-operation in cancer research among the 22 member organisations for the benefit of patients, the public and the scientific community.